RyvuTx

We’re proud to share that Ryvu has been recognized in the prestigious “#GiełdowaSpółkaRoku 2025” ranking. 🎉Among the 140 listed companies, we ranked: 🔟th in the main ranking 5️⃣th in Innovation in products and services 5️⃣th in Management Board competence

Ryvu w czołówce innowatorów w Polsce! W najnowszym zestawieniu Europejskiego Urzędu Patentowego jesteśmy pierwsi pod względem liczby zgłoszeń patentowych w obszarze odkrywania leków, jednocześnie będąc w pierwszej trójce firm z sektora prywatnego. lnkd.in/dRZt24FP

Staying a bit longer in Lisbon after #BIO Europe Spring? It’s also a good opportunity to visit the #LSX World Congress Europe and connect with Pawel Przewiezlikowski. Feel free to reach out!

Ryvu Therapeutics has reported its financial results for FY2025 and shared a corporate update. Read the press release: ryvu.com/press-release/…

Ryvu will be attending #BIO-Europe Spring 2026 in Lisbon, Portugal (March 23–25)! Don’t miss the opportunity to connect with Pawel Przewiezlikowski, Kamil Sitarz and Vatnak Vat-Ho. They’ll be on-site to discuss partnering opportunities and explore how we can work together.

Ryvu Therapeutics to present preclinical data on the ONCO Prime platform at the 2026 AACR Annual Meeting and announces PERO grant agreement Read more: lnkd.in/dhPinNb6

Już w najbliższy piątek zapraszamy na debatę w ramach Invest Cuffs z udziałem m.in. Pawła Przewięźlikowskiego pt.: „Made in Małopolska – jak regionalne marki walczą o globalny rynek”. investcuffs.pl/agenda/

Spółka Ryvu Therapeutics zawarła umowę z Narodowym Centrum Badań i Rozwoju o dofinansowanie nowego projektu! Więcej: ryvu.com/pl/raporty/rap…

Ryvu na Kongresie Wyzwań Zdrowotnych (#HCC2026)! 13 marca w godz. 11:30–13:00 Kamil Sitarz wystąpi podczas panelu dyskusyjnego pt.: „Badania kliniczne jako element systemu ochrony zdrowia – od B+R do pacjenta”. Zapraszamy! #RyvuTx #KongresWyzwańZdrowotnych #BadaniaKliniczne

Conference season is in full swing, and our CBO, Vatnak Vat-Ho, will be on the road connecting with partners across the biotech and healthcare ecosystem. Join him at: ✅ UBS Biotech Summit Miami ✅ Investival Showcase (LSX) ✅ Barclays 28th Annual Global Healthcare Conference

Pawel Przewiezlikowski will attend the 19th Annual European Life Sciences CEO Forum in Zurich on 4–5 March '26. If you’re attending, we’d be delighted to connect. Feel free to reach out to Paweł, schedule a meeting, and join the conversation!

We’re excited to attend the 16th World ADC London Summit - Europe’s flagship event focused on antibody-drug conjugates and cutting-edge targeted therapy innovation, taking place 23–26 February 2026 in London, UK. See you there!

Fresh clinical updates straight from #ASH2025! We’re pleased to share new data on #romaciclib and #dapolsertib presented during this year’s ASH Annual Meeting. 🔎 Download the posters: lnkd.in/dtPXCjUa 📃 Find out more: lnkd.in/dX2rwV2f

We’re excited to present new clinical data on #romaciclib (#RVU120) at the #ASH2025. Read the press release: ryvu.com/press-release/…

Join our online conference showcasing the recent progress from the Phase II studies of romacyclib (#RVU120): RIVER-81 and POTAMI-61. Sign up and watch the conference live: lnkd.in/dA5rsCuZ

We’re pleased to share an update on our Q3 2025 results, summarizing key developments across our pipeline and operations. Find out more: 🔗 Full financial report: lnkd.in/dQqH-kGj 🔗 Press release: lnkd.in/dU-E9CRq #RyvuTx #Q3FinancialReport #Romaciclib

Vatnak Vat-Ho will join the #LSX Investival Showcase in London on 17 November, representing Ryvu among industry innovators and investors. If you’d like to learn more about Ryvu’s portfolio, progress, or partnership potential, feel free to connect: lnkd.in/eP7Cz4CS

We’re excited to announce that we will present new clinical data on romaciclib (RVU120) and dapolsertib (MEN1703) at the #ASH Annual Meeting 2025 (December 6–10, Orlando, FL). 🔗 Check out the abstracts lnkd.in/dutFQd5  and visit ryvu.com for more.

Join us at the 16th #WorldADC in San Diego, November 3–6, 2025! Meet our team to exchange insights, explore collaboration opportunities, and discuss the next chapter of ADC innovation.

If you’re interested in the life sciences and biotech investment scene in Central and Eastern Europe, don’t miss the #LSBC conference in Krakow on October 30. Join the discussion with Kamil Sitarz, COO of Ryvu, and other leading experts. More: pe-lsbc2025.pl